IDEAYA Biosciences, Inc. - Common Stock (IDYA)
CUSIP: 45166A102
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,836,000
- Total 13F shares
- 34,102
- Share change
- -1,670
- Total reported value
- $1,135,616
- Price per share
- $33.32
- Number of holders
- 14
- Value change
- -$55,344
- Number of buys
- 3
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 45166A102:
Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
15%
|
13,149,960
|
$454,594,125 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
8.1%
from 13D/G
|
8,209,392
|
$283,798,682 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
13D/G
|
Company |
7.3%
from 13D/G
|
7,186,456
|
$248,344,296 | — | 31 Dec 2025 | |
| Capital Research Global Investors |
13D/G
13F
|
Company |
6%
|
5,279,675
|
$194,503,227 | -$46,897,909 | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.7%
|
5,019,324
|
$173,518,031 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.7%
|
4,134,641
|
$142,934,539 | — | 31 Dec 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
4.1%
|
3,618,826
|
$125,102,815 | — | 31 Dec 2025 | |
| FEDERATED HERMES, INC. |
13D/G
13F
|
Company |
3.9%
|
3,395,771
|
$117,393,162 | $0 | 31 Dec 2025 | |
| Logos Global Management LP |
13F
|
Company |
3.6%
|
3,125,000
|
$108,031,250 | — | 31 Dec 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.2%
|
2,800,000
|
$96,796,000 | — | 31 Dec 2025 | |
| Fiera Capital Corp |
13F
|
Company |
2.8%
|
2,437,262
|
$84,256,148 | — | 31 Dec 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.5%
|
2,153,043
|
$74,430,697 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
2,073,583
|
$71,694,992 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13D/G
13F
|
Company |
2.1%
|
1,844,556
|
$67,953,443 | -$94,600,552 | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2%
|
1,770,866
|
$61,218,838 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.6%
|
1,449,145
|
$50,098,000 | — | 31 Dec 2025 | |
| GSK plc |
13F
|
Company |
1.5%
|
1,333,333
|
$46,093,322 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
1,252,404
|
$43,295,630 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
1.2%
|
1,085,632
|
$37,530,298 | — | 31 Dec 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
1.2%
|
1,031,354
|
$35,655,426 | — | 31 Dec 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
1.1%
|
979,063
|
$33,846,208 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.1%
|
959,355
|
$33,164,903 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.1%
|
938,857
|
$32,456,177 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
902,973
|
$31,215,784 | — | 31 Dec 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1%
|
889,633
|
$30,754,612 | — | 31 Dec 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1%
|
885,121
|
$30,598,633 | — | 31 Dec 2025 | |
| Redmile Group, LLC |
13F
|
Company |
0.84%
|
742,017
|
$25,651,528 | — | 31 Dec 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.84%
|
734,335
|
$25,385,961 | — | 31 Dec 2025 | |
| First Turn Management, LLC |
13F
|
Company |
0.82%
|
723,653
|
$25,016,684 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.81%
|
714,633
|
$24,704,863 | — | 31 Dec 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.79%
|
697,925
|
$24,127,000 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
675,123
|
$23,339,003 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.68%
|
596,483
|
$20,620,417 | — | 31 Dec 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.64%
|
560,623
|
$19,380,737 | — | 31 Dec 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.58%
|
508,347
|
$17,573,556 | — | 31 Dec 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.58%
|
506,740
|
$17,518,002 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.53%
|
467,851
|
$16,173,609 | — | 31 Dec 2025 | |
| Iron Triangle Partners LP |
13F
|
Company |
0.53%
|
467,484
|
$16,160,922 | — | 31 Dec 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.51%
|
450,000
|
$15,556,500 | — | 31 Dec 2025 | |
| Yujiro S. Hata |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
1,290,695
mixed-class rows
|
$13,482,366 | — | 30 Jan 2026 | |
| Nuveen, LLC |
13F
|
Company |
0.43%
|
374,007
|
$12,929,422 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.42%
|
368,481
|
$12,738,388 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.34%
|
299,888
|
$10,367,128 | — | 31 Dec 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
284,069
|
$9,820,265 | — | 31 Dec 2025 | |
| GENERAL AMERICAN INVESTORS CO INC |
13F
|
Company |
0.32%
|
280,261
|
$9,688,623 | — | 31 Dec 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.32%
|
277,560
|
$9,595,249 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.29%
|
256,144
|
$8,854,863 | — | 31 Dec 2025 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.28%
|
250,000
|
$8,642,500 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.28%
|
244,041
|
$8,436,481 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.27%
|
240,209
|
$8,304,025 | — | 31 Dec 2025 |
Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q1 2026
As of 31 Mar 2026,
IDEAYA Biosciences, Inc. - Common Stock (IDYA) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,102 shares.
The largest 10 holders included
E Fund Management Co., Ltd., IFP Advisors, Inc, PARK AVENUE SECURITIES LLC, SIGNATUREFD, LLC, Versant Capital Management, Inc, GAMMA Investing LLC, Farther Finance Advisors, LLC, MassMutual Private Wealth & Trust, FSB, EASTERN BANK, and Sankala Group LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
242
Q1 2026 holders
14
Holder diff
-228
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.